Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Swiss biotech sector enjoys record growth

by Alex Scott
April 30, 2023 | A version of this story appeared in Volume 101, Issue 14

 

The biotech industry in Switzerland had a strong 2022, according to the annual report of the Swiss Biotech Association, an industry group. The sector landed record R&D investment, up 6.6% from 2021, to $3 billion, and record sales, up 2.6% to $7.5 billion. R&D jobs in the Swiss biotech sector increased 7.2% to 19,132 in 2022. About 20% of all European biotech firms now have their headquarters in Switzerland, according to the association.

Article:

This article has been sent to the following recipient:

1 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.